MAI Capital Management’s Boston Scientific BSX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$20.7M	Buy	330,209 +168,770	+105%	+$13.5M	0.12%	162
2025 Q4	$15.4M	Sell	161,439 -1,673	-1%	-$164K	0.09%	195
2025 Q3	$15.9M	Buy	163,112 +6,584	+4%	+$682K	0.1%	176
2025 Q2	$16.8M	Buy	156,528 +6,773	+5%	+$685K	0.12%	158
2025 Q1	$15.1M	Sell	149,755 -34,444	-19%	-$3.47M	0.11%	166
2024 Q4	$16.5M	Sell	184,199 -1,001	-0.5%	-$88.1K	0.12%	150
2024 Q3	$15.5M	Sell	185,200 -20,753	-10%	-$1.64M	0.15%	116
2024 Q2	$15.9M	Sell	205,953 -2,311	-1%	-$169K	0.16%	113
2024 Q1	$14.3M	Sell	208,264 -4,604	-2%	-$296K	0.15%	121
2023 Q4	$12.3M	Sell	212,868 -6,453	-3%	-$344K	0.16%	118
2023 Q3	$11.6M	Sell	219,321 -18,122	-8%	-$950K	0.17%	121
2023 Q2	$12.8M	Sell	237,443 -102,959	-30%	-$5.38M	0.19%	110
2023 Q1	$17M	Buy	340,402 +1,726	+0.5%	+$81.3K	0.27%	86
2022 Q4	$15.7M	Buy	338,676 +2,207	+0.7%	+$95.6K	0.26%	86
2022 Q3	$13M	Buy	336,469 +337	+0.1%	+$13.5K	0.25%	94
2022 Q2	$12.5M	Sell	336,132 -13,325	-4%	-$542K	0.24%	91
2022 Q1	$15.5M	Sell	349,457 -103,572	-23%	-$4.49M	0.26%	91
2021 Q4	$19.2M	Buy	453,029 +2,753	+0.6%	+$116K	0.31%	78
2021 Q3	$19.5M	Buy	450,276 +27,153	+6%	+$1.2M	0.38%	74
2021 Q2	$18.1M	Buy	423,123 +25,652	+6%	+$1.08M	0.36%	73
2021 Q1	$15.4M	Buy	397,471 +29,330	+8%	+$1.11M	0.35%	75
2020 Q4	$13.2M	Sell	368,141 -6,438	-2%	-$232K	0.34%	76
2020 Q3	$14.3M	Buy	374,579 +109,753	+41%	+$4.23M	0.42%	60
2020 Q2	$9.3M	Buy	+264,826	New	+$9.54M	0.3%	79